Analysts Viewpoint
IRWD’s latest rating updates from top analysts.
Ironwood Pharmaceuticals Inc’s recently made public that its Chief Executive Officer MCCOURT Thomas A unloaded Company’s shares for reported $7745.0
Menu
Ironwood Pharmaceuticals Inc’s recently made public that its Chief Executive Officer MCCOURT Thomas A unloaded Company’s shares for reported $7745.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Ironwood Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer MCCOURT Thomas A unloaded Company’s shares for reported $7745.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ironwood Pharmaceuticals
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ironwood Pharmaceuticals
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ironwood Pharmaceuticals
Ironwood Pharmaceuticals Inc’s recent filing unveils that its Officer MCCOURT Thomas A acquired Company’s shares for reported $8650.0 on May
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or